Crescom

(Photo: Artificial intelligence supports for timely determination of orthodontic treatment_ ⓒ Crescom Co., Ltd.)

Study of clinical validity and publication in international journal for prediction of SMI (skeletal maturity indicators) stage for orthodontics using artificial intelligence bone age solution.

Crescom, an artificial intelligence medical image analysis company led by CEO Jae Joon Lee, announced that the results of clinical validation for MediAI-BA's SMI stage prediction have been published in Scientific Reports, a related publication of the world-renowned journal, Nature. MediAI-BA is a hybrid artificial intelligence solution for growth plate analysis that combines the strengths of existing bone age reading techniques, namely GP and TW3, while addressing their weaknesses.

The Skeletal Maturation Indicators (SMI) are widely used in orthodontics to classify bone maturation. They analyze the hands and wrist bones to determine 11 stages of growth, including the gentle growth period, the rapid growth period, and the end of growth. It is widely acknowledged that establishing an appropriate orthodontic treatment plan based on a child's growth and developmental stage, is crucial.

In this study conducted by Professor Seong Hwan Choi's team at Yonsei University College of Dentistry in collaboration with a renowned orthodontist, the MediAI-BA's SMI prediction demonstrated clinically reliable performance and improved clinical efficiency in orthodontics. Furthermore, it has been confirmed that this can assist clinicians in improving the reproducibility of skeletal maturation assessments.

In addition to MediAI-BA, Crescom offers MediAI-OA, a quantitative evaluation solution for assessing the severity of knee osteoarthritis. This solution is currently being used review support tool for the Health Insurance Review and Assessment Service. Furthermore, the software offers specialized solutions for musculoskeletal disorders, including an artificial intelligence analysis solution for ankylosing spondylitis. This groundbreaking solution was published in an international journal, marking the first of its kind in the world.

Jae Joon Lee, the CEO of Crescom, said, “We are delighted to offer our advanced artificial intelligence solution to help dentists determine the optimal timing for orthodontic treatment and bone age growth examination."